. Author manuscript; available in PMC: 2015 Jul 1.

Published in final edited form as: Pharmacoepidemiol Drug Saf. 2014 Apr 22;23(7):745–752. doi: 10.1002/pds.3623

Table 5.

Results of Cox proportional hazard analysis of fluoroquinolone versus β-Lactam antibiotic prescription^*⁺

	Adjusted Hazard ratio	p-value	95% CI
	Adjusted Hazard ratio	p-value	Lower	Upper
7 Days after prescription	^**	^**	^**	^**
30 Days after prescription	0.56	0.57	0.08	4.14
90 Days after prescription	0.87	0.75	0.35	2.12
365 Days after prescription	0.89	0.60	0.58	1.36

Controlled for age

⁺

Other known associated systemic diseases, Marfan's and Stickler's Syndrome, were assessed, but found to occur in such small numbers as to be inconsequential to the results of the study and were not included in the final analysis

^**

Not able to calculate due to 0 events in fluoroquinolone group